AlphaValue Corporate Services
This research has been commissioned and paid for by the company and is deemed to constitute an acceptable minor non-monetary benefit as defined in MiFID II

Chargeurs

CR
Bloomberg   CRI FP
Support Services  /  France  Web Site   |   Investors Relation
From an industrialist to a luxury player?
Target
Upside 30.0%
Price (€) 11.32
Market Cap (€M) 285
Perf. 1W: 2.35%
Perf. 1M: -5.35%
Perf. 3M: -4.55%
Perf Ytd: -3.08%
10 day relative perf. to stoxx600: -0.92%
20 day relative perf. to stoxx600: -4.99%
EPS change02/09/2013

Deep, deep discount and firming up ground

Change in EPS2013 : € 0.29 vs 0.30-3.85%
2014 : € 0.52 vs 0.49+6.19%

Fine-tuning on EPS primarily combining a better outlook on Protection films and a more cautious one on Interlining with positive net implications on DCF-based valuations.



Change in DCF€ 6.58 vs 5.85+12.5%

Stronger DCF-based valuation on account of firmer earnings forecasts from 2014 onwards. Net debt at parent company level unchanged.



Updates

25 Nov 13 Other news/comments
Steady going over Q3

01 Sep 13 Earnings/sales releases
Corner turned?

24 Jan 13 Earnings/sales releases
€16m 2012 loss; regaining room for manoeuvre

26 Nov 12 Earnings/sales releases
Resistance of prices, drop in volumes

03 Oct 12 Earnings/sales releases
Worsening context weighs on profitability

04 May 12 Other news/comments
Lower volumes will impact profitability

.